Nice retrospective study on role of cytoreductive Nx in patients treated with ICI. Of Nx group, interesting that nearly 90% got up front surgery and only 10% delayed following ICI. Is this what most are doing? Sarah P. Psutka MD MS Mark Stein ari hakimi E Jason Abel sciencedirect.com/science/articl…

Half of surveyed patients wouldn't want systemic therapy for PFS gains only (without improvement in OS). Interesting, thought-provoking, not terribly surprising. Herbert Irving Comprehensive Cancer Center academic.oup.com/jnci/article/d…

We are live! I am alive?🤖 Start GAMIFYING your robotic surgical training here: bit.ly/robot-GAMERS #gamify #meded #roboticsurgery Society of Academic Urologists Intuitive Gina M. Badalato Chris Anderson George Moran

If no recurrence after 10 years of TURBT, discharge from clinic? Certainly not crazy based on this paper goldjournal.net/article/S0090-…

We are thrilled to welcome a new team member in 2024 🎊: Dr. Michael Feuerstein Mike Feuerstein will assume the role of Chief of Urology at NYP Westchester and Director of Urology for ColumbiaDoctors in Westchester.

✴️Take home points from an national survey of Society of Academic Urologists program directors on resident remediation . Great work by PGY5 David Han Chris Anderson Gina M. Badalato Tiffany Murano

So excited for you to join our family Columbia Urology! #AUAMatch24 Amer. Urol. Assn. Michigan Urology NYMC Urology

Congrats to our amazing home Columbia Vagelos College of Physicians & Surgeons students on the #AUAMatch24! So happy to welcome you into our profession and see your careers take off 🌠 at wonderful training programs! Jefferson Urology NYU Langone Urology Amer. Urol. Assn. Society of Academic Urologists

Would love to do this type of study for flexible cystoscopy. jamanetwork.com/journals/jamas…

jamanetwork.com/journals/jamas… 30 day postoperative mortality elevated for about 1 year after MI or stroke. Very useful data for counseling patients.

Fascintating: about a quarter of patients with with PSA 1.8-3 had pos MRI, and risk of csPrCA was 4.6%. PSA>3 csPrCA 9.3%. Interestingly, PIRADS appeared to perform the same regardless of PSA, although low PSA PIRADS 3 usually benign. sciencedirect.com/science/articl…

Novel data here. 1cm/mo thrombus growth seems fast to me (?wonder what median is), but I wouldn't plan a thrombectomy with month old imaging based on these findings. sciencedirect.com/science/articl…

Interesting XRT data for RCC. "we propose ... a randomized clinical trial of surgery versus SABR as the primary treatment modality in operable patients" with RCC. Agree, but would also throw in an observation arm. @_shankarsiva Herbert Irving Comprehensive Cancer Center thelancet.com/journals/lanon…

I’m not sure how I’d never heard of this, but what an amazing story. The day Iceland's women went on strike - BBC News bbc.com/news/magazine-…

Nearly a third of men over 80 getting screened for prostate cancer. A third! jamanetwork.com/journals/jaman…

Join us on July 19th for a CME event focused on genitourinary cancers. The full day includes didactic sessions and panel discussions covering the latest in cancer diagnosis, treatment advances, and team-based patient management approaches. Register here: columbiamed.link/3VU6OkD

Come learn more about our program and this wonderful family during our virtual Open House 🏡Thursday 8/29 at 5PM EST. Register here, and we will send you access information shortly before the event: nam02.safelinks.protection.outlook.com/?url=https%3A%…